Backyard Blue Zones

April 30, 2017 @ 7:27 am
posted by Dr Ginther

My backyard is drier than Katoski along Blackhawk Creek.  The spring wildflowers are different.

Scilla were first, followed by bloodroot.  Daffys and narcissus, each variety a few days later.  Bellwort is always brief.  False anemone, toothwort, black cohash, blue myrtle.  Prairie trillium are the best in the nearly 40 years I have savored them.  Redbuds are spectacular this year.  Mayapples, starry nose Soloman seal, lillies of the valley, Jacob’s ladder, true Soloman seal, shooting star, are up but not blooming yet.  French lilacs have started, but Miss Kim and Persian not yet.  Rose Rhododendrons are a mass of hudreds of blossoms.

Anther Blue Zones experience.

Jay Ginther, MD

Spring in Katoski Greenway

April 26, 2017 @ 8:12 pm
posted by Dr Ginther

Purple violets, spring beauty by the thousands, white violets, Virginia bluebells by the tens of thousands, yellow violets, trout lillies, a few early buttercups, the first time I have seen them blooming – stary Soloman’s plume, and a few ubiquitous dandylions by the parking lot.

Truely a Blue Zones experience!

Jay Ginther, MD

“Treat to Target” and “Use VFA” in 2017

April 23, 2017 @ 8:50 pm
posted by Dr Ginther

Clinical Osteoporosis 2017, NOF and ISCD joint meeting had a different emphasis this year.  Fracture Risk, rather than Bone Mineral Density (BMD) is now the key metric.  Several speakers emphasizd the importance of VFA in making the diagnosis of Clinical Osteoporosis.  This is something I have presented in poster exhibits 2015, 2016 and 2017.  I am now mainstream!

“Treat to Target” was the big new message this year.  We should set a target of decreased Fracture Risk for each patient and alter treatment until we reach it.  This has been routine for years in diabetes, hypertension, cholesterol, etc.  This is recognition that Osteoporosis is a chronic disease that we can control, but never cure, just like many others.

Take Control Naturally is the necessary first step, as I have outlined over the last few months.  This is often sufficient for prevention and in mild disease.

Advanced Osteoporosis, especially after fragility fractures, or vertebral compression fractures seen on VFA, is usually beyond nutrition and exercise only.  This will usually require medications to significantly reduce fracture risk.

The huge change is the recommendation to use an Anabolic medication first, to markedly reduce fracture risk, when BMD is very low or multiple fractures have already occured.  Then follow up with an Antiresorptive to maintain a low fracture risk.  Traditionally Medicare and other insurances have demanded we try Antiresorptives first to maintain bone as it is, even when multiple fractures have proven the bone to NOT be good enough at curent BMD.

We are entering a new age of Fracture Prevention!!

Jay Ginther, MD

NOF & ISCD at “Clinical Osteoporosis 2017”

April 17, 2017 @ 5:24 pm
posted by Dr Ginther

The National Osteoporosis Foundation (NOF) and the International Society for Clinical Densitometry (ISCD) are meeting together later this week.  This will be my 10th attendance at each group.  They are both always interesting.

I will be presenting a new research project this year – “Vertebral Compression Deformities in Patients with Normal Bone Mineral Density”.

This is a further study of the 79 patients with Normal BMD by DXA alone, who were changed to Clinical Osteoporosis because of vertebral compression fractures found on VFA from last year’s study of 1259 consecutive patients with first-time VFA at our facility.

I look forward to seeing what else is new this year.

Jay Ginther, MD